Stock image.Photo:Getty
Getty
Never miss a story — sign up forPEOPLE’s free daily newsletterto stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories.
Based on the study’s results, after five years, 80% of the women employing the new induction chemotherapy treatment were alive and 73% had not seen their cancer return or spread,The Guardianreported. In contrast, of those who received just the standard radiotherapy treatment, 72% were alive and 64% did not see their cancer return or spread.
She added, “This is the biggest improvement in outcome in this disease in over 20 years.”
Cancer Research U.K., the Britain-based charity that financed the study, described the results as “remarkable.”
“Timing is everything when you’re treating cancer,” said Dr. Iain Foulkes, executive director of research and innovation at Cancer Research U.K., perThe Guardian. “The simple act of adding induction chemotherapy to the start of chemoradiation treatment for cervical cancer has delivered remarkable results in this trial.”
“We’re excited for the improvements this trial could bring to cervical cancer treatment and hope short courses of induction chemotherapy will be rapidly adopted in the clinic,” Foulkes continued.
TheCenters for Disease Control and Prevention(CDC) says, there are approximately 11,500 new cases of cervical cancer diagnosed annually in the U.S. and 4,000 die as a result. The agency said that screening tests and the HPV vaccinecan aid in the prevention of the cancer, adding that the cancer is highly treatable if found early.
source: people.com
